Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 2029-2035

  Yuan, Menghui ^a   Wei, Longxiao ^a   Zhou, Runsuo ^a   Bai, Qianrong ^a   Wei, Yixin ^a   Zhang, Wei ^a   Huang, Yong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

FCRL3 gene; Haplotype; Multiple sclerosis; Single nucleotide polymorphisms

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FCRL3 GENE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BIOLOGICAL MODEL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS;

FCRL3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 84961140181     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9149-7     Document Type: Article

References (33)

1. Martinez A, Mas A, de Las Heras V, Bartolome M, Arroyo R, Fernandez-Arquero M, de la Concha EG, Urcelay E (2007) FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity? J Neuroimmunol 189(1–2):132–136. doi:10.1016/j.jneuroim.2007.06.018
2. Matesanz F, Fernandez O, Milne RL, Fedetz M, Leyva L, Guerrero M, Delgado C, Lucas M et al (2008) The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol 195(1–2):146–150. doi:10.1016/j.jneuroim.2008.01.004
3. Dyment DA, Ebers GC, Dessa Sadovnick A (2004) Genetics of multiple sclerosis. Lancet Neurol 3(2):104–110
4. Fedetz M, Matesanz F, Caro‐Maldonado A, Fernandez O, Tamayo J, Guerrero M, Delgado C, López Guerrero J et al (2006) OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68(5):446–449
5. Leyva L, Fernández O, Fedetz M, Blanco E, Fernández VE, Oliver B, León A, Pinto-Medel M-J et al (2005) IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. J Neuroimmunol 163(1):165–171
6. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S et al (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37(5):478–485. doi:10.1038/ng1540
7. Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramon E, Garcia-Hernandez FJ, Koeleman B et al (2006) Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45(8):1044–1046. doi:10.1093/rheumatology/kel160
8. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocr Metab 91(3):1056–1061. doi:10.1210/jc.2005-1634
9. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW (2007) FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 66(6):803–806. doi:10.1136/ard.2006.064949
10. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S (2006) Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55(9):1367–1368. doi:10.1136/gut.2006.095059
11. Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M et al (2001) Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 116(5):728–730. doi:10.1046/j.1523-1747.2001.01311.x
12. Dai KZ, Harbo HF, Celius EG, Oturai A, Sorensen PS, Ryder LP, Datta P, Svejgaard A et al (2001) The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Gen Immun 2(5):263–268. doi:10.1038/sj.gene.6363774
13. Chistiakov DA, Chistiakov AP (2007) Is FCRL3 a new general autoimmunity gene? Hum Immunol 68(5):375–383. doi:10.1016/j.humimm.2007.01.013
14. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275–290. doi:10.1146/annurev.immunol.19.1.275
15. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR (2007) Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocr Metab 92(3):1106–1111. doi:10.1210/jc.2006-2183
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231. doi:10.1002/ana.410130302
17. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265. doi:10.1093/bioinformatics/bth457
18. Eyre S, Bowes J, Potter C, Worthington J, Barton A (2006) Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? Arthritis Res Therapy 8(4):R117. doi:10.1186/ar2006
19. Begovich AB, Chang M, Schrodi SJ (2007) Meta-analysis evidence of a differential risk of the FCRL3–169 T– > C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 56(9):3168–3171. doi:10.1002/art.22857
20. Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C (2008) FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed Pharmacother 62(3):153–157. doi:10.1016/j.biopha.2007.09.003
21. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, Kamatani N (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65(5):671–673. doi:10.1136/ard.2005.043489
22. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, Johnson B, Greer W et al (2006) Rheumatoid arthritis association with the FCRL3–169C polymorphism is restricted to PTPN22 1858 T-homozygous individuals in a Canadian population. Arthritis Rheum 54(12):3820–3827. doi:10.1002/art.22270
23. Martinez A, Sanchez E, Valdivia A, Orozco G, Lopez-Nevot MA, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B et al (2006) Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1188–1191. doi:10.1136/ard.2005.048454
24. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, Criswell LA, Seldin MF et al (2006) The functional − 169 T → C single‐nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 54(3):1022–1025
25. Turunen JA, Wessman M, Kilpikari R, Parkkonen M, Forsblom C, Groop PH (2006) The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to Type 1 diabetes. Diabet Med 23(8):925–927. doi:10.1111/j.1464-5491.2006.01848.x
26. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD et al (2006) Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Gen 7:20. doi:10.1186/1471-2350-7-20
27. Zhao SX, Liu W, Zhan M, Song ZY, Yang SY, Xue LQ, Pan CM, Gu ZH et al (2013) A refined study of FCRL genes from a genome-wide association study for Graves’ disease. PLoS One 8(3):e57758. doi:10.1371/journal.pone.0057758
28. Zheng R, Zhao Z, Zhang S, Li R (2009) Study on the association of 3 SNPs of FcRL3 gene with Graves disease in Chongqing Han population. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin J Med Gen 26(6):681–685. doi:10.3760/cma.j.issn. 1003-9406.2009.06.016
29. Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P (2008) Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet’s disease in a Chinese population with ophthalmic manifestations. Mol Vis 14:2136–2142
30. Ehrhardt GR, Leu CM, Zhang S, Aksu G, Jackson T, Haga C, Hsu JT, Schreeder DM et al (2007) Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv Exp Med Biol 596:155–162. doi:10.1007/0-387-46530-8_14
31. Swainson LA, Mold JE, Bajpai UD, McCune JM (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184(7):3639–3647. doi:10.4049/jimmunol.0903943
32. Steinman L, Zamvil S (2003) Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 3(6):483–492. doi:10.1038/nri1108
33. Steinman L (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 9(6):440–447. doi:10.1038/nri2548